Clinical Study
Outcome and Prognostic Indicators of Patients with Hematopoietic Stem Cell Transplants Admitted to the Intensive Care Unit
Table 1
Clinical characteristics of HSCT patients requiring ICU admission.
| | Characteristics | HSCT patients requiring ICU () |
| | ICU admissions, | 179 | | Type of transplant, (%) | | | Autologous | 59 (38%) | | Allogeneic | 95 (62%) | | Age, mean (SD) | 44 (14) | | Days post-HSCT, median (IQR) | 48 (11, 208) | | ICU days, median (IQR) | 5 (2, 11) | | Gender, n (%) | | | Male | 91 (59%) | | Female | 63 (41%) | | Underlying disease, n (%) | | | Acute myeloid leukemia | 45 (29%) | | Non-hodgkin's lymphoma | 32 (21%) | | Acute lymphoblastic leukemia | 25 (16%) | | Hodgkin's lymphoma | 17 (11%) | | Multiple myeloma | 9 (6%) | | Chronic myeloid leukemia | 7 (4.5%) | | Breast cancer | 4 (2.6%) | | Myelodysplastic syndrome | 4 (2.6%) | | Aplastic anemia | 3 (1.9%) | | Paroxysmal nocturnal hemaglobinuria | 2 (1.3%) | | Chronic lymphoblastic leukemia | 2 (1.3%) | | Other | 4 (2.6%) | | Source of stem cell | | | Peripheral stem cell transplant | 139 (90%) | | Bone marrow transplant | 14 (9.0%) | | Cord blood | 1 (0.6%) | | GVHD, n (% of Allo HSCT) | 65 (68%) | | Neutropenia | 66 (43%) | | Mechanical ventilation | 110 (71%) | | Vasopressors | 104 (66%) | | Dialysis | 63 (41%) |
|
|
